Impact of Early Fortini Initiation on Growth and Interstage Outcomes in Infants With Single Ventricle Physiology
Part of paid clinical trials in Corpus Christi, Texas.
- Sponsor
- Driscoll Children's Hospital
- Study ID
- NCT07087782
- Status
- Recruiting
Conditions
- Single-ventricle
Eligibility Criteria
- Sex
- ALL
- Age
- 0 Months - 6 Months
- Healthy Volunteers
- Not accepted
Interventions
- Fortini formula — OTHERFortini, a commercially available formula providing 30 kcal/oz, is commonly used in older children with failure to thrive or feeding intolerance. It offers the theoretical benefit of providing higher caloric density in a lower volume, which may be advantageous in infants with single ventricle physiology, who often have limited volume tolerance and high metabolic demands.
- Standard Nutritional Care — OTHERStandard infant formulas (including hydrolyzed formulas) fortification to 24-30 kcal/oz
Study Details
This study is testing whether a special formula called Fortini, which is a high-calorie, low osmolality formula can help high-risk babies with single ventricle physiology grow better after their initial Stage 1 surgical palliation. These babies often struggle to gain weight, which can lead to more health problems before their next surgery. After their first heart surgery, but prior to discharge, babies will be randomly placed into two groups. One group will get Fortini formula when they leave the hospital, and the other group will get the standard of care high-calorie formula. The primary goal is to see if Fortini helps babies grow better by the time they are ready for their second surgery. The study will also check if the babies tolerate the formula well, how much they eat, how often they are re-admitted to the hospital, and how their caregivers feel about feeding. The babies will be followed for up to 4 months, until they return for their next surgery. About 100 infants are expected to join the study at Driscoll Children's Hospital. This research may help improve nutrition care for infants with complex heart conditions and reduce stress for their families.
Key Dates
- Start date
- Jul 30, 2025
- Status verified
- May 2026
- Primary completion
- Dec 31, 2028
- Completion
- Jun 30, 2029
Study Design
- Enrollment
- 100 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Experimental: Fortini FormulaFortini, a commercially available formula providing 30 kcal/oz
- Active Comparator: Standard nutritional careStandard infant formulas (including hydrolyzed formulas) fortification to 24-30 kcal/oz
Primary Outcome Measure
Change in weight-for-age Z-score (WAZ) [ Time Frame: 4-6 months ]
Central Contacts
- Sannya Hede, MD361-694-5000
- Erin Richmond361-694-5978
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Driscoll Children's Hospital | Corpus Christi | Texas | 78411 | Sannya Hede, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Corpus Christi, TX
Related Studies
- Characterizing the Effect of Dopamine on Markers of Lymph Re-circulation in Fontan-associated Protein-losing EnteropathyEnrolling By Invitation · University of Michigan · Ann Arbor, Michigan
- Two-Year Study of the Safety and Efficacy of the Second-Generation Tissue Engineered Vascular GraftsPHASE2 · Recruiting · Nationwide Children's Hospital · Columbus, Ohio
- Fibrosis and the FontanPHASE1/PHASE2 · Recruiting · Children's Hospital of Philadelphia · Philadelphia, Pennsylvania
- Ventripoint Single Ventricle StudyRecruiting · Duke University · Durham, North Carolina